Alesi Surgical is a leading innovator in the field of minimally invasive surgery technologies. The company has developed UltravisionTM, the world’s first system that eliminates laparoscopic surgical smoke without the need for gas exchange. Ultravision produces a low-energy electrostatic charge that can significantly improve visibility for surgeons by actively eliminating surgical smoke generated by energy-based surgical cutting instruments. In addition to improved visibility, Ultravision also allows reducing surgery time by almost 20%. Minimizing healthcare professionals’ exposure to surgical smoke is increasingly important worldwide because of health concerns over the risk of long-term exposure. The technology also benefits the patient as it minimizes the amount of cold, dry carbon dioxide gas used during surgery. Excessive use of carbon dioxide leads to cardiovascular problems, complications in anesthesia, post-surgical pain and longer recovery time for the patient.
Total raised: $6.732599M

Investors 1

Mentions in press and media 2

01.06.2017Term Sheet...EXITS AND CONFLICTS NYC Tech:...--fortune.co...
31.05.2017Alesi Surg...Alesi Surgical Limited, a Card...UK-finsmes.co...